The latest information for November 11, 2021
The latest information for November 11, 2021
Together Communtiy Update

Thursday, November 11, 2021

CF Foundation Strikes First-Of-Its-Kind Deal With Pioneering Medicines

As part of our Path to a Cure research agenda, we announced a collaboration with Pioneering Medicines, an initiative of Flagship Pioneering, to accelerate the development of genetic-based therapies for cystic fibrosis. We expect to invest up to $110 million in the collaboration, with an initial commitment of $20 million and the option to invest additional funds as promising therapies arise.

Pfizer Vaccine Authorized for Children Ages 5 to 11

The vaccine from Pfizer-BioNTech (COMIRNATY®) has been authorized for children ages 5 to 11 years. You can find a vaccination site at vaccines.gov, and via your health department, local school system, or pediatrician's office. The CF Foundation recommends vaccination for all who are eligible.
Make a vaccine appointment »

Need Help This Open Enrollment Season?

Open enrollment ends soon: Have you evaluated your health insurance options yet? Work with a Compass case manager one-on-one to compare plans that provide the specialized care and treatment that you or your loved one needs. Contact the Compass team today and get started.

Register for our Genetic Therapies Webinar

Genetic therapies hold the potential to treat the underlying cause of the disease for everyone with cystic fibrosis, regardless of mutation. Register for our last research webinar of the year on Tuesday, December 14 at 7 p.m. ET, for an introduction to RNA and gene therapy. Attendees can also ask questions during the audience Q&A.

Help Shape Our Research Around CF-Related Complications

Share your experiences with cystic fibrosis-related complications such as advanced lung disease, CF-related diabetes, mental health, and more by applying to share your input at the Guidance Action Projection workshop. This virtual opportunity will help guide the Foundation on what research and funding is needed most around CF-related complications. Join Community Voice to receive this opportunity and apply by Monday, November 15.
  We will not rest until we find a cure  
Opt-out of this mailing list
Opt-out of all CFF emails